Navigate with confidence
Enhance your ability to go after hard-to-reach lung nodules with the MONARCH Platform
The MONARCH™ Platform is the first flexible, robotically assisted platform for bronchoscopy.1 It provides access to and visualization of airways2,3 to enable healthcare providers to biopsy suspicious lung nodules.2,4,5 An earlier diagnosis is crucial in accelerating opportunities for treatment discussions.6
Technology to get you there and the evidence to prove it
Smart navigation
The MONARCH Platform leverages AI-powered algorithms for navigation and image processing7
Stable reach & precise control
Access all eighteen segments of the lung5 to reach small peripheral lesions8A
Continuous vision
Maintain sight with continuous visualization throughout the procedure.2
MONARCH™ QUEST 3, our latest software launch, has been cleared by the FDA
MONARCH™ QUEST 3 is designed to deliver:
- A more precise 3D model of the target nodule1
- Improved registration and navigation accuracy2
- Enhanced visual orientation during targeting3
- Broader 3D imaging system compatibility3
Gustavo Cumbo-Nacheli, MD
Interventional Pulmonology
Corewell Health
Confidently biopsy with the MONARCH™ Platform
Reach further into the lungs
Approximately 48% of nodules are located in the peripheral third of the lung, so you need to go further.8 The telescoping scope and sheath design can be articulated independently and can redirect insertion force, enabling you to reach further into the lung, allowing you to make small adjustments to place the biopsy needle into different areas of the nodule.2,5
Enhance your ability to go after hard-to-reach lung nodules
The MONARCH™ Platform, from Johnson & Johnson MedTech, is the first flexible, robotic-assisted platform for bronchoscopy.1 It provides access to and visualization of airways to enable healthcare providers to biopsy suspicious lung nodules.2,5 An earlier diagnosis is crucial in accelerating opportunities for treatment discussions.6
.jpg?width=3840&quality=90&format=webp)
Real-time visualization
An integrated camera enables visualization during a procedure and can help you orient and adjust tools, such as radial endobronchial ultrasound.2,5
Driven to improve lung cancer outcomes
Johnson & Johnson is dedicated to improving outcomes by integrating our MedTech and Innovative Medicine expertise to improve the tools for diagnosing lung cancer and allowing physicians to create treatment options.
Provides ergonomic comfort
The controller enables you to sit, stand close or far away from the patient, or move around the intraoperative space.13B
Supporting documentation
Webpage
Webpage
Webpage
Webpage
Webpage
References
Bronchoscopy Indications for Use: The MONARCH™ Platform and its accessories are intended to provide bronchoscopic visualization of and access to patient airways for diagnostic and therapeutic procedures.
Bronchoscopy Important Safety Information: Complications from bronchoscopy may include breathing difficulty, vocal cord spasm, hoarseness, slight fever, vomiting, dizziness, bronchial spasm, infection, low blood oxygen, bleeding from biopsied site, or an allergic reaction to medications. More serious complications from bronchoscopy may include collapsed lung, respiratory failure, hemorrhage, burns, heart attack, or cardiac arrhythmia.
A. 679 patients received a robotic-assisted bronchoscopy with median lesion size 18.5 (13.5-26.5) mm and median distance from pleural surface 5 (0-16) mm.
B. MONARCH Bronch 2.0 DVAL report - Functionality, Dec. 2019.
- Auris Health, Inc. Technical Review for New Prep Nodule Segmentation Algorithm. February 2025.
- Auris Health, Inc. Technical Review for Vision 6DoF in Initial Registration. July 2025
- Auris Health, Inc. Project Authorization Charter
- U.S Food & Drug Administration. 510(k) Premarket Notification. Bronchoscope, flexible or rigid. K152819. Accessed November 26, 2024..
- AURIS. 104-002610-01. MONARCH Platform System Design Verification Report B2.0. December 2019.
- Chen AC, Pastis NJ, Silvestri GA, et al. Robotic bronchoscopy for peripheral pulmonary lesions: a multicenter pilot and feasibility study (BENEFIT). Chest. 2021;159(2):845-852.
- Murgu S, Sterman D, Yasufuku K, et al. Demographic and lesion characteristics in the first 443 subjects enrolled in a multicenter observational real-world robotic bronchoscopy study: interim results from TARGET. Poster presented at: American Association for Bronchology and Interventional Pulmonology 2022 Annual Conference; August 11-13, 2022; Nashville, TN.
- Chen AC, Gillespie CT. Robotic endoscopic airway challenge: REACH assessment. Ann Thorac Surg. 2018;106(1):293-297.
- Khan F, Seaman J, Hunter TD, et al. Diagnostic outcomes of robotic-assisted bronchoscopy for pulmonary lesions in a real-world multicenter community setting. BMC Pulm Med. 2023;23(1):161.
- Auris, Software Design Document. May 2024.
- Murgu S, Sterman D, Chen A, et al. Prospective, Muli-Center Evaluation of Safety and Diagnostic Accuracy with Robotic-Assisted Bronchoscopy: Results of the Transbronchial Biopsy Assisted by Robot Guidance in the Evaluation of Tumors of the Lung (TARGET) Trial. American College of Chest Physicians Conference. October 08, 2024.
- MONARCH™ Platform User Manual. May 2025,
- Auris, Design Validation Summary Report. Oct. 2024.
- Auris, Software Design Document. May 2024.
- Auris, Technical Review. 2024.
- Auris, 103-000615-00 Bronch 2.3 Claims Matrix Rationale, June 2021, Validation Test Report.
For complete indications, contraindications, warnings, precautions, and adverse reactions, please reference full package insert.
US_SRG_RADS_389015.1